Background and Purpose-An acute mismatch on diffusion-weighted MRI (DWI) and perfusion-weighted MRI (PWI) may represent the "tissue-at-risk." It is unclear which "semiquantitative" perfusion parameter most closely identifies final infarct volume. Methods-Acute stroke patients underwent DWI and PWI (dynamic-susceptibility contrast imaging) on admission (baseline), and T 2 -weighted imaging (T 2 WI) at 1 or 3 months after stroke. "Semiquantitative" mean transit time (MTT sq ϭfirst moment of concentration/time curve), cerebral blood volume (CBV sq ϭarea under concentration/time curve), and cerebral blood flow (CBF sq ϭCBV sq /MTT sq ) were calculated. DWI and PWI lesions were measured at baseline and final infarct volume on T 2 WI acquired Ն1 month after stroke. Baseline DWI, CBF sq , and MTT sq lesion volumes were compared with final T 2 WI lesion volume.
I n acute ischemic stroke, the mismatch between the acute lesion on magnetic resonance (MR) diffusion-weighted imaging (DWI) and perfusion-weighted imaging (PWI) may represent the "ischemic penumbra" or "tissue-at-risk" of infarction 1 and may provide a target of salvageable tissue within and possibly beyond 6 hours. 2 In several studies, the presence of an acute PWI lesion larger than the DWI lesion at baseline predicted ischemic lesion growth on final (Ն1 month) T 2 -weighted imaging (T 2 WI). 3, 4 One month is the minimum time at which final infarct extent should be assessed as "fogging" may obscure, 5 and edema may exaggerate 6 T 2 WI infarct extent measured at Ͻ1 month.
Perfusion information from MR dynamic-susceptibility contrast (DSC) PWI uses "semiquantitative" or "quantitative" analyses. 7 We used "semiquantitative" (also called "summary" or "relative" 7 ) to describe analyses of the concentration/time curve without correction with the arterial input function (AIF). In general, "semiquantitative" measures require less intensive processing than "quantitative" measures 8 and include parameters such as: time-to-peak (TTP), which may be a good estimate of mean transit time (MTT) 9 but is difficult to compare between imaging episodes; 7 cerebral blood volume (CBV sq ), calculated from the area under, and MTT sq , calculated from the first moment of, the concentration/time curve; 7 and cerebral blood flow (CBF sq ), calculated as CBV sq /MTT sq . 10 "Quantitative" perfusion (also called "absolute" 7 ) requires deconvolution of the concentration/time curve with an AIF: 7, 8 CBF q may be calculated as the height, and CBV q as the area under, the deconvolved concentration/ time curve; and MTT q as CBV q /CBF q . 7, 8 CBV is not considered a good predictor of "tissue-at-risk" because of its bimodal nature and insensitivity to bolus delay and dispersion. 11 Thus, parameters reflecting CBF and MTT have emerged as the most likely candidates for predicting final infarct extent.
Previous studies of PWI data (Ͻ24 hours after stroke) and final lesion extent (Table 1) have produced rather confusing results. Of the 13 studies, only 3 compared CBF q and MTT q (total nϭ53): [11] [12] [13] 2 found that CBF q and 1 that MTT q related best to final infarct volume. None directly compared CBF sq and MTT sq . In the remainder, TTP correlated strongly with final infarct volume 4,6 and MTT sq and MTT q overestimated final infarct volume. 14 -21 Only 4 studies included pa- tients who did not receive thrombolysis or experimental agents. 11, 12, 15, 20 The small sample sizes (Table 1) , different PWI lesion measurement methods, inappropriate statistical tests (parametric versus nonparametric), and total absence of data comparing CBF sq and MTT sq (more rapidly calculated than "quantitative" data acutely) indicate that more data are required to determine which PWI parameter identifies "tissue-at-risk."
We aimed to determine whether CBF sq or MTT sq on acute DSC PWI most closely identified the final T 2 WI infarct extent, the relationship of "DWI/PWI mismatch" and lesion growth, and to identify possible reasons for discrepancies in previous studies.
Methods

Patients
We prospectively recruited patients from the hospital stroke service with moderate to severe ischemic stroke. We performed imaging urgently (maximum for the study of 24 hours after stroke onset [baseline]). Baseline clinical assessment including the National Institutes of Health Stroke Scale (NIHSS) score and Oxfordshire Community Stroke Project (OCSP) classification were performed by a trained stroke physician. Functional outcome (modified Rankin scale [mRS]) was measured at 3 months. A panel of experts determined a final diagnosis of stroke. We recorded any acute treatments that the patients received (treatment did not affect inclusion in study).
Imaging
We used a GE Signa LX 1.5T (General Electric) MR scanner with a self-shielding gradient set (22 mT/m maximum) and "birdcage" quadrature head coil. We included fast spin-echo T 2 WI and gradientecho T 1 -weighted sequences, a spin-echo echo-planar (EP) imaging diffusion tensor protocol (DT-MRI), and DSC PWI. For DT-MRI, sets of axial diffusion-weighted EP images (bϭ0 and 1000 s/mm 2 ) were collected with diffusion gradients applied sequentially along 6 noncollinear directions (5 acquisitions including baseline T 2 WI EP image and 6 diffusion-weighted EP images per slice position). PWI was measured by tracking gadolinium diethylenetriamine pentaacetic acid, injected intravenously by MR-compatible pump injector, for 85 s using a single-shot gradient-echo EP sequence. The DWI/PWI sequences used: 15 axial slices, 5-mm slice thickness, 1-mm slice gap, 128ϫ128 image matrix, and 24ϫ24 cm field-of-view.
Image Processing
"Semiquantitative" PWI parameters were calculated in each voxel from the signal intensities in the component EP images 8 by fitting the data to a ␥-variate curve. Maps of CBV sq (area under fitted concentration/time curve), MTT sq (first moment of fitted concentration/time curve), and CBF sq (CBV sq /MTT sq ), 8 were generated for each voxel, converted into Analyze (Mayo Foundation) format and presented as a color-coded map. Voxels in which the data did not reach a maximum value of Ͼ2ϫ the maximum precontrast baseline signal SD and then begin to fall before the end of the imaging time (85 seconds) were assigned as error voxels, visible as white areas on the perfusion color maps (there were extremely few patients with any of these), indicating very low flow areas in the infarct.
Baseline PWI and DWI and Final T 2 WI Lesion Volume Analysis
A neuroradiologist, blind to all clinical and other imaging data, guided the tracing by an experienced neuroscientist of the visible lesions on DWI, CBF sq , and MTT sq . maps, using a Sun Ultra Sparc Station 10 (Sun Microsystems) in Analyze (ie, a consensus of 2 experienced observers). Image brightness and contrast were optimized between areas of abnormal diffusion or perfusion and normalappearing brain. The neuroradiologist also traced the final infarct on the latter of the 1-or 3-month T 2 WI as described above. Lesion volumes were obtained by summing the number of outlined voxels and multiplying by the slice thickness on each slice on which the lesion was visible.
Statistical Analyses
Baseline DWI, CBF sq , MTT sq , and final T 2 WI lesion volumes were not normally distributed (Kolmogorov-Smirnov test; PϽ0.01), so median lesion volumes were compared using Wilcoxon signed rank sum tests, and correlations between baseline DWI, CBF sq , and MTT sq volumes with final T 2 WI lesion volume were assessed with Spearman rank correlation coefficients (). We also calculated mean volumes (ϮSD) for comparison with previous studies (Table 1) , and Pearson product moment correlation coefficients (r, appropriate for parametric data) to compare baseline DWI, CBF sq , and MTT sq with final T 2 WI lesion volume, to determine whether use of Pearson r might explain differences between previous studies. "Lesion growth" was defined as final T 2 WI lesion volumeϾbaseline DWI lesion volume, and "DWI/PWI mismatch" as PWI lesion volumesϾDWI lesion volumes. 2 tests were used to test whether DWI/CBF sq or DWI/MTT sq "mismatch" predicted "lesion growth."
Results Patients
A total of 46 patients were included; 28 of 46 (61%) were male, with an average age of 72 years (range 37 to 94 years). Mean NIHSS score on admission was 8 (median 8; range 0 to 25). For OCSP classifications, 12 of 46 (26%) patients had a total anterior circulation infarct, 29 of 46 (63%) had a partial anterior circulation infarct, 4 of 46 (9%) had a lacunar infarct, and 1 of 46 (2%) had a posterior circulation infarct. All patients were treated with aspirin, but none received thrombolysis or investigational drugs. Mean mRS score at 3 months was 2 (median 2); 2 of 46 (4%) patients were dead (mRSϭ6), and 13 of 46 (28%) patients were dependent (mRSϭ3 to 5). Mean (ϮSD) time from stroke onset to baseline MRI was 10Ϯ7 hours; 18 of 46 (39%) patients were imaged within 6 hours, 11 of 46 (24%) at 6 to 12 hours, and 17 of 46 (37%) at 12 to 24 hours. Final T 2 WI was performed at 1 month (mean 32Ϯ4 days) in 6 of 46 (13%) patients and at 3 months (mean 96Ϯ7 days) in 40 of 46 (87%) patients.
Baseline PWI Lesion Volumes (Table 2)
Baseline CBF sq lesion volumes (median 23.74 cm 3 ) were significantly smaller than baseline MTT sq lesion volumes (median 50.60 cm 3 ; PϽ0.01). Eleven patients (24%) had no visible lesion on baseline CBF sq , and 10 patients (22%) had no visible lesion on baseline MTT sq ; 6 (13%) had no visible lesion on either baseline CBF sq or MTT sq .
Baseline DWI Lesion Volumes (Table 2 and Figure 1)
All patients had a visible baseline DWI lesion. Baseline DWI lesion volumes (median 13.28 cm 3 ) were significantly smaller than baseline CBF sq (Pϭ0.01) and MTT sq volumes (PϽ0.01) but were not significantly different from final T 2 WI lesion volume (Pϭ0.14). 
Baseline PWI Versus Final T 2 WI Lesion Volumes (Table 2 and Figure 1)
All patients had a visible lesion on final T 2 WI (median 18.47 cm 3 ) corresponding with the lesion indicated on baseline DWI. Overall, baseline CBF sq lesion volume was not significantly different from final T 2 WI lesion volume (Pϭ0.82). Baseline MTT sq volume was significantly larger (PϽ0.01) than final T 2 WI lesion volume.
Correlation Between Baseline DWI, PWI, and Final T 2 WI (Table 2 and Figure 1)
Final T 2 WI lesion volume most strongly correlated with baseline DWI (ϭ0.68), followed by baseline CBF sq (ϭ0.55) and baseline MTT sq (ϭ0.49) lesion volumes (all PϽ0.01). Using Pearson's r, final T 2 WI lesion volume was most strongly correlated with baseline MTT sq (rϭ0.66), followed by baseline DWI (rϭ0.53) and baseline CBF sq (rϭ0.41) lesion volumes (all PϽ0.01).
"DWI/PWI Mismatch" and Final T 2 WI Lesion Volume
There was no significant association between "lesion growth" (final T 2 WI lesionϾbaseline DWI lesion) and the presence or absence of "DWI/PWI mismatch" (Table 3) . On CBF sq , 15 of 25 patients with "mismatch" had "lesion growth," and 10 of 25 patients did not; 11 of 21 without "mismatch" had "lesion growth," and 10 of 21 did not ( 2 ϭ0.27; Pϭ0.60; Table 3 ). On MTT sq , 21 of 33 with "mismatch" had "lesion growth," and 12 of 33 did not; 5 of 13 without "mismatch" had "lesion growth," and 8 of 13 did not ( 2 ϭ2.40; Pϭ0.12; Table 3 ). Thus, about half of patients without "mismatch" had lesions that grew, and "mismatch" was as common among patients with lesions that grew as among those with lesions that did not grow (Figure 2 ).
Discussion
Because there were no previous studies testing the relationship between acute CBF sq and MTT sq and final infarct volume, we asked: which "semiquantitative" PWI parameter, if any, best predicts final infarct extent? In this large systematic study, we found that acute CBF sq lesions more closely identified final T 2 WI lesion extent than acute MTT sq lesions, which clearly overestimate final lesion extent. We also demonstrate that "lesion growth" was equally common among patients with and without "DWI/PWI mismatch": half "CBF sq /MTT sq Ͼbaseline DWI"ϭ"mismatch"; "Ͻbaseline DWI" or "no visible lesion"ϭno "mismatch." "Final T 2 WI volumeϾbaseline DWI"ϭ"lesion growth"; "Final T 2 WI volumeϽbaseline DWI"ϭno "lesion growth." Figure 2 . Examples of a patient with no "DWI/PWI mismatch" whose lesion grew between baseline DWI and final T 2 WI (A) and a patient with acute DWI/CBF sq and DWI/MTT sq mismatch whose lesion did not grow between baseline DWI and final T 2 WI (B). If the DWI/PWI mismatch theory were correct, then the initial infarct in A should not have grown (note on the 4-day DWI and final T 2 that the infarct clearly involves much more of the cortex) and in B, the initial infarct should have grown to involve a large portion of the middle cerebral artery (MCA) territory cortex (note on the final T 2 that the overlying MCA territory cortex is intact). the patients without a "mismatch" had "lesion growth"; half of those with "mismatch" did not. Although "DWI/PWI mismatch" is being used to identify patients for inclusion in trials of stroke treatments, our results imply that patients without "mismatch" may also benefit and should not be denied that possibility by being excluded.
Our findings concerning "semiquantitative" PWI parameters agree overall with the few previous "quantitative" studies directly comparing CBF q and MTT q . [11] [12] [13] Some disparities among previous studies may result from different statistical analyses; use of Pearson r instead of Spearman completely changed the strength and order of correlation between baseline CBF sq and MTT sq lesions and final T 2 WI lesion volume. Previous studies also support the conclusion that acute MTT (MTT sq or MTT q ) lesions overestimate final lesion extent, [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] although some studies found stronger correlations between MTT and final infarct volumes than we did (eg, ϭ0.77 to 0.90 12, 13, 19, 20 ) ; these studies used MTT q , were small (mean nϭ21; Table 1 ), and tested some very restricted perfusion thresholds (eg, highest 70% of MTT signal intensities 12 ). Furthermore, it is important to distinguish between "correlation" and "size equivalence"; a good correlation between baseline MTT volume and final T 2 WI lesion volume is not incompatible with MTT significantly overestimating final infarct volume.
In contrast to some previous studies, 4, [11] [12] [13] 16, 19, 20 we found no significant association between DWI/CBF sq or DWI/ MTT sq "mismatch" and "lesion growth" (Table 3 ). However, some of these studies only included patients with "mismatch." 11, 12 A recent study using "DWI/PWI mismatch" as an inclusion criteria in a thrombolysis trial 22 failed to show an association between "DWI/PWI mismatch" and lesion expansion but did show that reperfusion was inversely associated with "lesion growth."
The superiority of "quantitative" over "semiquantitative" PWI measures is not yet proven. "Quantitative" measures are still only estimates 7 and require considerably more complex image processing than "semiquantitative" measures so are less appropriate to the acute setting. Newer perfusion measures including flow heterogeneity 21 and bolus-delay corrected maps 13 appear promising, but further validation is required to determine their overall usefulness. There is a further question concerning the use of the term "perfusionweighted imaging" itself, which is somewhat misleading because MR perfusion maps are actually calculated parameter maps.
The strengths of the current study include the large sample, inclusion of patients with and without "DWI/PWI mismatch," careful clinical characterization, blinded image analysis and outcome assessment, and careful use of statistics. We included patients up to 24 hours, and interestingly most (75% to 80%) had a perfusion lesion on CBF, MTT, or both, with only just Ͼ10% not having a perfusion lesion. We used manual rather than "threshold" measurement methods because the former is currently the most rapid method to apply in the clinical setting. Thresholds might reduce observer variation, but the hemodynamics underlying ischemic stroke are complex and variable. Baseline perfusion values greatly overlap between tissue that does and does not infarct, 12, 17 and PWI parameter thresholds are time dependent; a threshold for ischemic but viable brain at 3 hours may be very different from that at 6 hours. None of our patients received thrombolysis or any investigational drugs, therefore this series represents a baseline measure of the presence or absence of spontaneous lesion expansion and could be used to estimate sample sizes for future acute stroke treatment trials using imaging markers of outcome. However, our data emphasize the need for further study to identify which, if any, alternative imaging markers might identify patients in whom treatments such as thrombolysis might prevent infarct growth. For example, it is unclear precisely how large artery patency relates to the PWI lesion. Are middle cerebral artery or internal carotid artery occlusions always accompanied by PWI lesions, and do these lesions resolve completely and rapidly as the artery reperfuses, or is there a time lag between arterial reperfusion and PWI lesion disappearance?
In conclusion, acute DWI, CBF sq , and MTT sq lesion volumes all correlated well with final infarct volume, but acute MTT sq lesion volume significantly overestimated final infarct volume. Of the 2 "semiquantitative" PWI measures, the acute CBF sq lesion most closely identifies the final T 2 WI lesion. There was no clear association between the presence of a "DWI/PWI mismatch" and lesion expansion, questioning the value of the "DWI/PWI mismatch" as a clinical marker of "tissue-at-risk." About half of patients without "DWI/PWI mismatch" have "lesion growth" so they may benefit from acute stroke treatments and should probably not be excluded from clinical trials.
